TITLE

Diagnosing Lynch syndrome: is the answer in the mouth?

AUTHOR(S)
Roy, H. K.; Lynch, H. T.
PUB. DATE
December 2003
SOURCE
Gut;Dec2003, Vol. 52 Issue 12, p1665
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Risk stratification is essential for designing efficacious and cost effective colon cancer screening programmes. One of the most important risk factors for colorectal cancers is an inherited predisposition, implicated in 20% of all cases. The spectrum of genetic susceptibility ranges from the low penetrance mutations that modestly increase the colon cancer risk to the much more dramatic phenotypes that engender an extraordinarily high risk of cancer. Lynch syndrome or hereditary non-polyposis coborectal cancer is a case in point. This autosomal dominant condition results from a germline mutation in a DNA mismatch repair gene.
ACCESSION #
12940900

 

Related Articles

  • Risks of Lynch Syndrome Cancers for MSH6 Mutation Carriers. Baglietto, Laura; Lindor, Noralane M.; Dowty, James G.; White, Darren M.; Wagner, Anja; Garcia, Encarna B. Gomez; Vriends, Annette H. J. T.; Cartwright, Nicola R.; Barnetson, Rebecca A.; Farrington, Susan M.; Tenesa, Albert; Hampel, Heather; Buchanan, Daniel; Arnold, Sven; Young, Joanne; Walsh, Michael D.; Jass, Jeremy; Macrae, Finlay; Antill, Yoland; Winship, Ingrid M. // JNCI: Journal of the National Cancer Institute;Feb2010, Vol. 102 Issue 3, p193 

    Background: Germline mutations in MSH6 account for 10%–20% of Lynch syndrome colorectal cancers caused by hereditary DNA mismatch repair gene mutations. Because there have been only a few studies of mutation carriers, their cancer risks are uncertain.

  • Genetic and Epigenetic Marker-Based DNA Test of Stool Is a Promising Approach for Colorectal Cancer Screening. Sung Whan An; Nam Kyu Kim; Hyun Cheol Chung // Yonsei Medical Journal;6/30/2009, Vol. 50 Issue 3, p331 

    Colorectal cancer (CRC) is one of the most common malignancies and leading cause of cancer-related deaths in the world. However, it may be treated effectively by surgical removal of the cancerous tissue if detected at early stages. Conventional tools for screening CRC are either invasive or...

  • G-C heterozygosis in mutS homolog2 as a risk factor to hereditary nonpolyposis colon cancer in the absence of a family medical history. Arvayo-Zatarain, Jorge Alfonso; Grijalva-Chon, José Manuel; Castro-Longoria, Reina; Varela-Romero, Alejandro // Indian Journal of Human Genetics;May-Aug2011, Vol. 17 Issue 2, p90 

    To detect the presence of point mutations in a small section of the mutS homolog2 (MSH2) gene in both healthy and affected persons treated at the General Hospital of the State of Sonora, a 353 base pair section of the MSH2 gene was amplified and sequenced from six persons affected by hereditary...

  • The Mutyh Base Excision Repair Gene Influences the Inflammatory Response in a Mouse Model of Ulcerative Colitis. Casorelli, Ida; Pannellini, Tania; Luca, Gabriele De; Degan, Paolo; Chiera, Federica; Iavarone, Ivano; Giuliani, Alessandro; Butera, Alessia; Boirivant, Monica; Musiani, Piero; Bignami, Margherita // PLoS ONE;2010, Vol. 5 Issue 8, p1 

    Background: The Mutyh DNA glycosylase is involved in the repair of oxidized DNA bases. Mutations in the human MUTYH gene are responsible for colorectal cancer in familial adenomatous polyposis. Since defective DNA repair genes might contribute to the increased cancer risk associated with...

  • Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival. Slattery, Martha L.; Lundgreen, Abbie; Bondurant, Kristina L.; Wolff, Roger K. // Carcinogenesis;Nov2011, Vol. 32 Issue 11, p1660 

    Interferons (IFNs) are proteins involved in many functions including antiviral and antimicrobial response, apoptosis, cell cycle control and mediating other cytokines. IFN gamma (IFNG) is a proinflammatory cytokine that modulates many immune-related genes. In this study we examine genetic...

  • Randomized Trial of Different Screening Strategies for Colorectal Cancer: Patient Response and Detection Rates. Segnan, Nereo; Senore, Carlo; Andreoni, Bruno; Arrigoni, Arrigo; Bisanti, Luigi; Cardelli, Alessandro; Castiglione, Guido; Crosta, Cristiano; DiPlacido, Roberta; Ferrari, Arnaldo; Ferraris, Roberto; Ferrero, Franco; Fracchia, Mario; Gasperoni, Stefano; Malfitana, Giuseppe; Recchia, Serafino; Risio, Mauro; Rizzetto, Mario; Saracco, Giorgio; Spandre, Mauro // JNCI: Journal of the National Cancer Institute;3/2/2005, Vol. 97 Issue 5, p347 

    Background: Although there is general consensus concerning the efficacy of colorectal cancer screening, there is a lack of agreement about which routine screening strategy should be adopted. We compared the participation and detection rates achievable through different strategies of colorectal...

  • ASK DR ANDREW.  // Woman's Day (Australia Edition);8/8/2005, Vol. 57 Issue 32, p69 

    Provides information on colorectal cancer. Clinical screening of individual at-risk for colorectal cancer; Risk factors for colorectal cancer.

  • The Increasing Incidence of Colorectal Cancers Diagnosed in Subjects Under Age 50 Among Races: CRaCking the Conundrum. Carethers, John; Carethers, John M // Digestive Diseases & Sciences;Oct2016, Vol. 61 Issue 10, p2767 

    No abstract available.

  • Increasing late stage colorectal cancer and rectal cancer mortality demonstrates the need for screening: a population based study in Ireland, 1994-2010. Clarke, Nicholas; McDevitt, Joseph; Kearney, Patricia M.; Sharp, Linda // BMC Gastroenterology;2014, Vol. 14 Issue 1, p1 

    Background This paper describes trends in colorectal cancer incidence, survival and mortality from 1994 to 2010 in Ireland prior to the introduction of population-based screening. Methods We examined incidence (National Cancer Registry Ireland (NCRI) and mortality (Central Statistics Office)...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics